Live Webinar: 18 November 2021, 4 pm CET
Organised by ECTS
Date & Time: 18 November 2021, 4 pm CET
Featuring Prof. Dr. Rik Lories, and moderated by
- 5 min welcome & introductions
- 35 min presentation
- 20 min Q&A
- Understand molecular mechanisms involved in new bone formation in axial spondyloarthritis – ankylosing spondylitis
- Get insights into the relationship between inflammation and new bone formation in this disease
- Learn about new hypotheses on the role of biomechanics in these processes.
The New bone formation in axial spondylarthritis, Brussels, Belgium, 18-11-2021 has been
accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s).
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”
Rik Lories is Full Professor at KU Leuven. He is the Chair of the Department of Development and Director of the Skeletal Biology and Engineering Research Center that includes the Laboratory for Tissue Homeostasis and Disease that he is leading together with Prof. Silvia Monteagudo. He is the Chair of the Division of Rheumatology at the University Hospitals Leuven.
His research focuses on endogenous tissue responses in the joint with specific attention towards translational questions in chronic arthritis, in particular osteoarthritis, axial spondyloarthritis, and psoriatic arthritis. He obtained his medical degree summa cum laude in 1996. In 2003, he was certified as rheumatologist. In 2003 he also obtained a PhD in biomedical sciences at KU Leuven.
He is board member of the Osteoarthritis Research Society International (OARSI), of the Royal Belgian Society of Rheumatology and Scientific Chair of the Rheumatology Research Fund Belgium. Currently, he serves as associate editor for the journals Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage. He has (co-)authored > 160 publications, including original research reports or reviews in Nature Medicine, Science Translational Medicine, Nature Communications, Journal of Clinical Investigation, PNAS, Nature Reviews Rheumatology and Annals of the Rheumatic Diseases.